ENDRA Life Sciences Inc. (NDRA)
US — Healthcare Sector
Automate Your Wheel Strategy on NDRA
With Tiblio's Option Bot, you can configure your own wheel strategy including NDRA - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol NDRA
- Rev/Share 0.3795
- Book/Share 3.1437
- PB 1.1006
- Debt/Equity 0.335
- CurrentRatio 3.8534
- ROIC -2.9428
- MktCap 2554760.0
- FreeCF/Share -11.7573
- PFCF -0.3897
- PE -0.1975
- Debt/Assets 0.1852
- DivYield 0
- ROE -1.9624
- Rating B-
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 5
- P/B Score 4
- D/E Score 2
Recent Analyst Ratings
Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
---|---|---|---|---|---|---|---|
No ratings available. |
News
About ENDRA Life Sciences Inc. (NDRA)
- IPO Date 2017-06-30
- Website https://www.endrainc.com
- Industry Medical - Diagnostics & Research
- CEO Alexander Y. Tokman
- Employees 21
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.